Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benatti, P.
Right arrow Articles by Lanza, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benatti, P.
Right arrow Articles by Lanza, G.
Clinical Cancer Research Vol. 11, 8332-8340, December 1, 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Microsatellite Instability and Colorectal Cancer Prognosis

Piero Benatti1, Roberta Gafà3, Daniela Barana5, Massimiliano Marino1, Alessandra Scarselli1, Monica Pedroni1, Iva Maestri3, Laura Guerzoni3, Luca Roncucci1, Mirco Menigatti1, Barbara Roncari1, Stefania Maffei1, Giuseppina Rossi1, Giovanni Ponti1, Alessandra Santini4, Lorena Losi2, Carmela Di Gregorio6, Cristina Oliani7, Maurizio Ponz de Leon1 and Giovanni Lanza3

Authors' Affiliations: Departments of 1 Medicine and Medical Specialties, and 2 Pathology, University of Modena and Reggio Emilia, Modena; 3 Department of Experimental and Diagnostic Medicine, University of Ferrara, 4 Division of Clinical Oncology, St. Anna Hospital, Ferrara; 5 Department of Pathology, University of Verona; 6 Pathology Unit of Civil Hospital of Carpi, Carpi; and 7 Complex Operative Unit of Oncology, Ovest Vicentino, Vicenza, Italy

Requests for reprints: Piero Benatti, Medicine and Medical Specialties, University of Modena and Reggio Emilia, via del Pozzo 71, 41100 Modena, Italy. Phone: 39-59-422-2631; Fax: 39-59-422-2958; E-mail: pbenatti{at}unimo.it.

Purpose: Many studies have evaluated the role of high levels of microsatellite instability (MSI) as a prognostic marker and predictor of the response to chemotherapy in colorectal cancer (CRC); however, the results are not conclusive. The aim of this study was to analyze the prognostic significance of high levels of MSI (MSI-H) in CRC patients in relation to fluorouracil-based chemotherapy.

Experimental Design: In three different institutions, 1,263 patients with CRC were tested for the presence of MSI, and CRC-specific survival was then analyzed in relation to MSI status, chemotherapy, and other clinical and pathologic variables.

Results: Two hundred and fifty-six tumors were MSI-H (20.3%): these were more frequently at a less advanced stage, right-sided, poorly differentiated, with mucinous phenotype, and expansive growth pattern than microsatellite stable carcinomas. Univariate and multivariate analyses of 5-year–specific survival revealed stage, tumor location, grade of differentiation, MSI, gender, and age as significant prognostic factors. The prognostic advantage of MSI tumors was particularly evident in stages II and III in which chemotherapy did not significantly affect the survival of MSI-H patients. Finally, we analyzed survival in MSI-H patients in relation to the presence of mismatch repair gene mutations. MSI-H patients with hereditary non–polyposis colorectal cancer showed a better prognosis as compared with sporadic MSI-H; however, in multivariate analysis, this difference disappeared.

Conclusions: The type of genomic instability could influence the prognosis of CRC, in particular in stages II and III. Fluorouracil-based chemotherapy does not seem to improve survival among MSI-H patients. The survival benefit for patients with hereditary non–polyposis colorectal cancer is mainly determined by younger age and less advanced stage as compared with sporadic MSI-H counterpart.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
I. Zlobec, K. Baker, L. M. Terracciano, and A. Lugli
RHAMM, p21 Combined Phenotype Identifies Microsatellite Instability-High Colorectal Cancers with a Highly Adverse Prognosis
Clin. Cancer Res., June 15, 2008; 14(12): 3798 - 3806.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. A. Chan, J. A. Meyerhardt, D. Niedzwiecki, D. Hollis, L. B. Saltz, R. J. Mayer, J. Thomas, P. Schaefer, R. Whittom, A. Hantel, et al.
Association of Family History With Cancer Recurrence and Survival Among Patients With Stage III Colon Cancer
JAMA, June 4, 2008; 299(21): 2515 - 2523.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
I Zlobec and A Lugli
Prognostic and predictive factors in colorectal cancer
J. Clin. Pathol., May 1, 2008; 61(5): 561 - 569.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Imai and H. Yamamoto
Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics
Carcinogenesis, April 1, 2008; 29(4): 673 - 680.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. Weichert, A. Roske, S. Niesporek, A. Noske, A.-C. Buckendahl, M. Dietel, V. Gekeler, M. Boehm, T. Beckers, and C. Denkert
Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo
Clin. Cancer Res., March 15, 2008; 14(6): 1669 - 1677.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. A. Newcomb, Y. Zheng, V. M. Chia, L. M. Morimoto, V. P. Doria-Rose, A. Templeton, S. N. Thibodeau, and J. D. Potter
Estrogen Plus Progestin Use, Microsatellite Instability, and the Risk of Colorectal Cancer in Women
Cancer Res., August 1, 2007; 67(15): 7534 - 7539.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Malesci, L. Laghi, P. Bianchi, G. Delconte, A. Randolph, V. Torri, C. Carnaghi, R. Doci, R. Rosati, M. Montorsi, et al.
Reduced Likelihood of Metastases in Patients with Microsatellite-Unstable Colorectal Cancer
Clin. Cancer Res., July 1, 2007; 13(13): 3831 - 3839.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. R. Boland
Clinical Uses of Microsatellite Instability Testing in Colorectal Cancer: An Ongoing Challenge
J. Clin. Oncol., March 1, 2007; 25(7): 754 - 756.
[Full Text] [PDF]


Home page
GutHome page
J J L Wong, N J Hawkins, and R L Ward
Colorectal cancer: a model for epigenetic tumorigenesis
Gut, January 1, 2007; 56(1): 140 - 148.
[Full Text] [PDF]


Home page
GutHome page
J M Carethers
Authors' reply.
Gut, December 1, 2006; 55(12): 1819 - 1819.
[Full Text] [PDF]


Home page
GutHome page
R Jover, A Castells, X Llor, and M Andreu
Authors' reply.
Gut, December 1, 2006; 55(12): 1819 - 1820.
[Full Text] [PDF]


Home page
GutHome page
B Iacopetta and T Watanabe
Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
Gut, November 1, 2006; 55(11): 1671 - 1672.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Watanabe, T. Kanazawa, Y. Kazama, J. Tanaka, T. Tanaka, S. Ishihara, H. Nagawa, P. Benatti, M. Ponz de Leon, R. Gafa, et al.
Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability.
Clin. Cancer Res., June 15, 2006; 12(12): 3866 - 3867.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.